Select Publications
Book Chapters
2022, 'Gynaecological Cancer in Older Adults with Frailty', in Frailty in Older Adults with Cancer, pp. 447 - 466, http://dx.doi.org/10.1007/978-3-030-89162-6_25
,2021, 'Prevention of chemotherapy-induced peripheral neuropathy (CIPN): Current clinical data and future directions', in Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy: A MASCC Book, pp. 125 - 136, http://dx.doi.org/10.1007/978-3-030-78663-2_5
,2013, 'Pharmacology of Chemotherapy', in Stuart M Lichtman MD; Audisio RA (ed.), Management of Gynecological Cancers in Older Women, Springer Verlag
,2004, 'Supportive treatment in gynecologic malignancies', in Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches, pp. 233 - 244
,2000, 'Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer.', in Strickland A (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd002889
,2000, 'Chemotherapy and radiotherapy for pancreatic cancer', in Yip D (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd002093
,Journal articles
2024, 'Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial', The Lancet Oncology, 25, pp. 1135 - 1146, http://dx.doi.org/10.1016/S1470-2045(24)00334-6
,2024, 'Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group', ESMO Open, 9, http://dx.doi.org/10.1016/j.esmoop.2024.103657
,2024, 'Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer', International Journal of Epidemiology, 53, http://dx.doi.org/10.1093/ije/dyae108
,2024, 'Clinical impact of molecular profiling in the national prospective cohort Solving Unknown Primary Cancer (SUPER) study.', Journal of Clinical Oncology, 42, pp. 3056 - 3056, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3056
,2024, 'Age-friendly healthcare: integrating the 4Ms to enable age-friendly cancer care', Current Opinion in Supportive and Palliative Care, 18, pp. 9 - 15, http://dx.doi.org/10.1097/SPC.0000000000000687
,2024, 'Supportive and palliative care for older adults with cancer; facilitating person-centred, age friendly care', Current Opinion in Supportive and Palliative Care, 18, pp. 1 - 2, http://dx.doi.org/10.1097/SPC.0000000000000689
,2024, 'AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab (pan) plus 5 fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer—A trial by the Australasian Gastro-Intestinal Trials Group (AGITG).', Journal of Clinical Oncology, 42, pp. 3535 - 3535, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3535
,2023, 'FEAR OF CANCER RECURRENCE IN OLDER WOMEN IN REMISSION FROM GYNAECOLOGICAL CANCER IN REGIONAL AUSTRALIA', Innovation in Aging, 7, pp. 1042 - 1042, http://dx.doi.org/10.1093/geroni/igad104.3349
,2023, 'THE ROLE OF AGE-FRIENDLY HEALTH CARE IN OLDER ADULTS WITH CANCER', Innovation in Aging, 7, pp. 198 - 198, http://dx.doi.org/10.1093/geroni/igad104.0651
,2023, 'The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review', Journal of Geriatric Oncology, 14, http://dx.doi.org/10.1016/j.jgo.2023.101585
,2023, 'Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort', Journal of Geriatric Oncology, 14, http://dx.doi.org/10.1016/j.jgo.2023.101621
,2023, 'Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older', Cancer Epidemiology, 86, http://dx.doi.org/10.1016/j.canep.2023.102444
,2023, 'COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort study', The Lancet Regional Health - Western Pacific, 38, http://dx.doi.org/10.1016/j.lanwpc.2023.100824
,2023, 'Geriatric Oncology in the Instagram Era: Feasibility and Acceptability Randomised Controlled Trial on Adopting PhotoVoice to Enable Empowerment, Patient-Centred Care, and Shared Decision Making—Study Protocol', Methods and Protocols, 6, http://dx.doi.org/10.3390/mps6040068
,2023, 'Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study', Supportive Care in Cancer, 31, http://dx.doi.org/10.1007/s00520-023-07889-y
,2023, 'ASCEND: A randomised, double-blinded, phase II study of gemcitabine and nab‐paclitaxel with CEND‐1/LSTA1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma.', Journal of Clinical Oncology, 41, pp. TPS4197 - TPS4197, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps4197
,2023, 'Circulating tumor DNA (ctDNA) as a marker of residual disease and recurrence in resected stage I-IV epithelial ovarian cancer (EOC).', Journal of Clinical Oncology, 41, pp. 5553 - 5553, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.5553
,2023, 'Integrated care for older people with cancer: a primary care focus', The Lancet Healthy Longevity, 4, pp. e243 - e245, http://dx.doi.org/10.1016/S2666-7568(23)00058-2
,2023, 'Olaparib in HR-deficient (HRD), metastatic triple-negative breast cancer (TNBC) and relapsed ovarian cancer (ROC) without germline mutations in BRCA1 or BRCA2: Phase 2 EMBRACE trial.', Journal of Clinical Oncology, 41, pp. e15079 - e15079, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15079
,2023, 'Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation', European Journal of Cancer, 183, pp. 109 - 118, http://dx.doi.org/10.1016/j.ejca.2023.01.016
,2023, 'Supportive and palliative care for older adults with cancer', Current Opinion in Supportive and Palliative Care, 17, pp. 1 - 2, http://dx.doi.org/10.1097/SPC.0000000000000633
,2023, 'Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer', BJU International, 131, pp. 179 - 182, http://dx.doi.org/10.1111/bju.15930
,2023, 'Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary', Journal for ImmunoTherapy of Cancer, 11, http://dx.doi.org/10.1136/jitc-2022-005809
,2023, 'Perioperative Beta-Blocker Supply and Survival in Women with Epithelial Ovarian Cancer and a History of Cardiovascular Conditions', Journal of Clinical Oncology, 41, pp. 266 - 275, http://dx.doi.org/10.1200/JCO.22.00097
,2023, 'A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary', Journal of Pathology, 259, pp. 81 - 92, http://dx.doi.org/10.1002/path.6022
,2023, 'Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?', Expert Review of Pharmacoeconomics and Outcomes Research, 23, pp. 231 - 239, http://dx.doi.org/10.1080/14737167.2023.2161048
,2023, 'Implementation of Enhanced Supportive Care for Older Adults at an Australian Regional Cancer Centre', Journal of Geriatric Oncology, 14, pp. S41 - S41, http://dx.doi.org/10.1016/s1879-4068(23)00339-9
,2022, 'IMPLEMENTING AND MEASURING IMPACT OF A FIVE-YEAR TRANSLATIONAL GERIATRIC ONCOLOGY RESEARCH PROGRAM', Innovation in Aging, 6, pp. 235 - 236, http://dx.doi.org/10.1093/geroni/igac059.934
,2022, 'Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study', Supportive Care in Cancer, 30, pp. 8217 - 8229, http://dx.doi.org/10.1007/s00520-022-07228-7
,2022, 'Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older (vol 114, djac050, 2022)', JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 114, pp. 1206 - 1206, http://dx.doi.org/10.1093/jnci/djac118
,2022, 'Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older', Journal of the National Cancer Institute, 114, pp. 878 - 884, http://dx.doi.org/10.1093/jnci/djac050
,2022, 'Response to Lehrer and Rheinstein', JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, http://dx.doi.org/10.1093/jnci/djac083
,2022, 'Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial', The Lancet Oncology, 23, pp. 362 - 373, http://dx.doi.org/10.1016/S1470-2045(21)00757-9
,2022, 'Supportive and palliative care for older adults with cancer', Current Opinion in Supportive and Palliative Care, 16, pp. 1 - 2, http://dx.doi.org/10.1097/SPC.0000000000000586
,2022, 'Exercise as a supportive care strategy in men with prostate cancer receiving androgen deprivation therapy at a regional cancer centre: a survey of patients and clinicians', Supportive Care in Cancer, 30, pp. 1379 - 1389, http://dx.doi.org/10.1007/s00520-021-06512-2
,2022, 'Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial', Annals of Oncology, 33, pp. 67 - 79, http://dx.doi.org/10.1016/j.annonc.2021.09.011
,2022, '165P Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer', Annals of Oncology, 33, pp. S1498 - S1499, http://dx.doi.org/10.1016/j.annonc.2022.10.202
,2022, 'Geriatric Assessment in the instagram Era: The Addition of Patient Derived Photographs and Photovoice Discussion to an Electronic Geriatric Assessment to Enhance the Supportive Care of Older Adults with Cancer', Journal of Geriatric Oncology, 13, pp. S57 - S57, http://dx.doi.org/10.1016/s1879-4068(22)00379-4
,2021, 'MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08644-4
,2021, 'The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation core', Journal of Geriatric Oncology, 12, pp. 1164 - 1165, http://dx.doi.org/10.1016/j.jgo.2021.04.001
,2021, 'Supportive and palliative care of older adults with cancer', Current Opinion in Supportive and Palliative Care, 15, pp. 1 - 2, http://dx.doi.org/10.1097/SPC.0000000000000538
,2021, 'Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative', The Lancet Oncology, 22, pp. e29 - e36, http://dx.doi.org/10.1016/S1470-2045(20)30473-3
,2021, 'The Elderly Functional Index (ELFI), a patient-reported outcome measure of functional status in patients with cancer: a multicentre, prospective validation study', The Lancet Healthy Longevity, 2, pp. e24 - e33, http://dx.doi.org/10.1016/S2666-7568(20)30036-2
,2021, '1827P European Society for Medical Oncology (ESMO)/International Society of Geriatric Oncology (SIOG) Joint Working Group (WG) survey on management of older patients with cancer', Annals of Oncology, 32, pp. S1237 - S1238, http://dx.doi.org/10.1016/j.annonc.2021.08.715
,